Renal cell carcinoma - Latest research and news | Nature
WEBSep 19, 2024 — Renal cell carcinoma (RCC) refers to a heterogenous group of cancers that originate in the proximal convoluted tubule of the kidney. The three most common forms of RCC are clear cell RCC ...
Renal cancer - Latest research and news - Nature
WEB4 days ago — Non-coding transcriptome profiles in clear-cell renal cell carcinoma. In this Perspective, the authors provide an overview of the most promising deregulated non-coding RNAs in clear-cell renal ...
Renal cell carcinoma - Nature Reviews Disease Primers
WEBMar 9, 2017 — Renal cell carcinoma (RCC) encompasses a heterogeneous group of cancers derived from renal tubular epithelial cells 1 and is among the 10 most common cancers worldwide.
Uncovering a link between COVID-19 and renal cell carcinoma
WEBMar 13, 2023 — The proximal tubules are also the cellular origin for most renal cell carcinomas (RCCs), including clear cell RCC (ccRCC) and papillary RCC (pRCC).
Proteomic signatures of clear cell renal cell carcinoma
WEBNov 28, 2019 — In recent years, the molecular view of clear cell renal cell carcinoma (ccRCC) has been based primarily on gene transcription data with limited information on protein features. A new study led by ...
Renal cell carcinoma | Nature Reviews Urology
WEBIn this Review, the authors discuss advantages and complications associated with renal mass biopsy and provide an overview of different features of both well-recognized types of renal cell ...
The immunology of renal cell carcinoma - Nature
WEBJul 30, 2020 — Here, the authors describe the effector cell populations and immunosuppressive networks that are present in renal cell carcinoma (RCC) tumours. They also discuss the use of immune checkpoint ...
The shifting treatment paradigm of metastatic renal cell carcinoma …
WEBSep 5, 2022 — The treatment landscape of renal cell carcinoma is rapidly evolving, especially with the introduction and approval of immune checkpoint inhibitor combination therapies.
Determinants of renal cell carcinoma invasion and metastatic
WEBOct 4, 2021 — Tumor invasion is essential for metastatic spread. However, determinants of invasion are poorly understood. We addressed this knowledge gap by leveraging a unique attribute of kidney cancer. Renal ...
Perioperative immunotherapy for renal cell carcinoma: looking …
WEBNov 23, 2022 — The first phase III trial to test perioperative immune-checkpoint inhibitor therapy for high-risk renal cell carcinoma yielded highly promising results, leading to regulatory approvals of adjuvant ...